FDA Refuses To Review Moderna’s Flu Vaccine
Digest more
Many public-health authorities recommend the shingles vaccine for people between 65 and 80 (although the range varies by region). The sharp age cut-offs used in the roll-out in each country or region, combined with the large number of people vaccinated, has set up a natural experiment for researchers keen to study their effects.
Walensky is a professor at Harvard Medical School and served as the 19th director of the Centers for Disease Control and Prevention. Once clinical trials showed that Covid-19 vaccines were safe and effective in children and the FDA granted their emergency ...
One panelist accused the F.D.A. of withholding data on potential harms. The advisers also are reviewing research on vaccines given to pregnant women.
In December, the Centers for Medicare and Medicaid Services announced an end to state vaccine reporting requirements, effectively reversing a 2024 mandate.
Experts worry Robert F. Kennedy Jr.’s Health Department will use an internal AI tool to analyze vaccine injury claims in a way that furthers his anti-vaccine agenda.
Regulators move the goalposts for a manufacturer that uses mRNA technology.
From early failures to prefusion F protein breakthroughs, RSV vaccine development has accelerated, reshaping prevention strategies for infants and older adults.
Refusal to review the submission is inconsistent with feedback at pre-Phase 3 and pre-submission consultations; Moderna
Physician and public health groups urged a court Friday to block the Center for Disease Control and Prevention’s decisions to reduce the recommended vaccine shots for kids, canceling the federal advisory panel’s meeting later this month,